|Articles|August 27, 2015

Admedus Adopts the Medidata Clinical Cloud® in Vaccine Study

Author(s)Applied Clinical Trials Editorial Staff

Admedus adopts the Medidata Clinical Cloud® to bring greater speed and efficiency to it’s genital herpes therapeutic vaccine study.

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, announced that Australian-based specialist healthcare company Admedus is using its Medidata Clinical Cloud^® platform in its clinical development of a therapeutic vaccine for genital herpes.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Admedus Adopts the Medidata Clinical Cloud® in Vaccine Study

Related Content

Why Execution Strategy Begins at the Business Decision, Not Study Startup

ACT Brief: Sponsor Accountability in Outsourcing, Biomarker Strategy in Precision Oncology, and Novel Sciatica Therapy

Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology

The Quiet Misconception Behind Most Clinical Execution Failures

ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN

Trending on Applied Clinical Trials Online

Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology

ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN

ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor

Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose

The Quiet Misconception Behind Most Clinical Execution Failures